West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,600 | 256,800 | 252,000 | 207,100 | 255,300 |
| Receivables | 181,400 | 194,600 | 198,800 | 189,500 | 179,000 |
| Inventories | 181,100 | 187,700 | 187,200 | 183,400 | 181,500 |
| Income taxes - deferred | N/A | 8,300 | 8,200 | 8,700 | 7,800 |
| Other current assets | 36,600 | 33,500 | 33,700 | 36,400 | 35,500 |
| TOTAL | $673,700 | $680,900 | $679,900 | $625,100 | $659,100 |
| Non-Current Assets | |||||
| PPE Net | 721,000 | 689,500 | 685,400 | 675,800 | 705,800 |
| Investments And Advances | 61,300 | 59,200 | 59,800 | 59,300 | 60,600 |
| Intangibles | 142,200 | 144,300 | 144,700 | 144,600 | 150,600 |
| Other Non-Current Assets | 96,900 | 92,600 | 93,900 | 91,200 | 93,600 |
| TOTAL | $1,021,400 | $985,600 | $983,800 | $970,900 | $1,010,600 |
| Total Assets | $1,695,100 | $1,666,500 | $1,663,700 | $1,596,000 | $1,669,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 119,800 | 93,600 | 91,400 | 88,500 | 103,100 |
| Accrued Expenses | 53,000 | 56,200 | 52,400 | 38,800 | 52,900 |
| Other current liabilities | 59,400 | 60,100 | 56,400 | 55,500 | 54,400 |
| TOTAL | $314,300 | $299,900 | $313,700 | $296,600 | $252,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 228,900 | 231,500 | 231,700 | 231,900 | 308,300 |
| aiOther Non-Current Liabilities | 115,600 | 130,400 | 112,800 | 111,000 | 136,300 |
| TOTAL | $356,900 | $371,300 | $360,600 | $358,300 | $460,300 |
| Total Liabilities | $671,200 | $671,200 | $674,300 | $654,900 | $712,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,334 | 72,088 | 72,004 | 71,948 | 71,495 |
| Common Shares | 18,100 | 18,000 | 18,000 | 18,000 | 17,800 |
| Retained earnings | 964,600 | 939,900 | 947,000 | 927,200 | 902,200 |
| Other shareholders' equity | -162,600 | -154,400 | -160,200 | -170,500 | -119,300 |
| TOTAL | $1,023,900 | $995,300 | $989,400 | $941,100 | $956,900 |
| Total Liabilities And Equity | $1,695,100 | $1,666,500 | $1,663,700 | $1,596,000 | $1,669,700 |